Altria Group Inc

Analysts expect Altria to report revenues of $5.08 billion in the second quarter of 2020—a fall of 2.2% from $5.19 billion in the second quarter of 2019.

Philip Morris stock has risen as much as 3.2% in the pre-market session today as of 8:55 AM ET. The company posted its second-quarter results.

This year, Philip Morris stock has been subdued, losing 13.6% of its value. The company is set to report its second-quarter earnings on July 21.

Today, Gaurav Jain of Barclays downgraded Altria Group (NYSE:MO) from “overweight” to “equal weight.” He also lowered his target price from $50 to $43.

On Tuesday, the FDA authorized Philip Morris’s IQOS, an electrically heated tobacco unit, to be marketed as a modified risk tobacco product.

So far this year, Philip Morris (NYSE:PM) has lost 17.0% of its stock value. The stock has underperformed the broader equity markets.

Procter & Gamble’s strong underlying sales, margin expansion, and consistent dividend growth make it a top stock for income-seeking investors.

Layoffs amid COVID-19 led to a decline in disposable income, which had a negative impact on the cigarette and cannabis industries.

So far this year, Philip Morris International (NYSE:PM) and Altria Group (NYSE:MO) have underperformed the broader equity markets.

Investing in Altria stock is a no-brainer considering the company’s solid track record of dividend payments and low valuation.

Despite the impressive first-quarter performance, Philip Morris’s stock price has declined. As of May 7, the company was trading at $70.14.

Cronos Group (NASDAQ:CRON) will likely report its results for the first quarter of fiscal 2020 on May 8 before the market opens.

As of April 29, Cronos Group was trading at 8.63 Canadian dollars—a fall of 4.3% since the company reported its fourth-quarter earnings.

Today, Altria reported its first-quarter earnings. For the quarter, the company reported an adjusted EPS of $1.09 on net revenues of $5.05 billion.

Currently, 14 analysts cover Altria stock. Many analysts have a bullish view on the stock due to its higher dividend yield and lower valuation.

Philip Morris reported its earnings results for the first quarter of 2020. The company reported an adjusted EPS of $1.21 on revenues of $7.15 billion.

As of April 13, Philip Morris (NYSE:PM) was trading at 73.95—a fall of 11.3% since the announcement of its fourth-quarter earnings on February 6.

Cronos Group will report its fourth-quarter and fiscal 2019 results after the market closes today—a delay from the original date of February 27.

Investors should find safety in high-yielding dividend stocks amid the downturn. Altria and Philip Morris both deliver stable earnings and constant dividends.

On March 16, Morgan Stanley upgraded Altria Group (NYSE:MO) from “equal weight” to “overweight” with a target price of $49.

As of March 10, Philip Morris (PM) was trading at $84.73—a fall of 0.4% since the beginning of this year. PM has outperformed the broader equity market and its peers.

As of March 6, Altria Group (NYSE:MO) was trading at $42.15—a fall of 15.9% since the company reported its earnings for the fourth quarter of 2020 on January 30.

MKM Partners analyst Bill Kirk likes Cronos Group’s healthy cash position, strong track record, and its relationship with Altria (NYSE:MO).

Cronos Group will report its fourth-quarter earnings before the market opens on Thursday. Analysts expect double-digit revenue growth sequentially.

Today, Philip Morris reported its fourth-quarter earnings. For the quarter, the company posted an adjusted EPS of $1.22 on revenues of $7.71 billion.

Philip Morris will report its Q4 earnings before the market opens on Thursday. Analysts expect the company’s revenue to rise and its adjusted EPS to fall. 

Today, Altria Group reported its fourth-quarter earnings, which ended on December 31. For the quarter, the company reported revenue of $6.0 billion.

On January 2, as reported by CNBC, the FDA banned most fruit- and mint-flavored nicotine products. The move aims to reduce teen usage of these products.

In addition to boosting dividends, many consumer stocks saw stellar growth in 2019. Most of these companies outperformed the benchmark index YTD.

Consumer stocks like Macy’s (M), Kraft Heinz (KHC), Gap (GPS), Altria (MO), and Walgreens (WBA) are lagging the broader markets by a wide margin.

Most consumer stocks have outperformed the broader markets so far this year amid an improved macroeconomic backdrop and the industry’s defensive nature.

In this morning’s edition of our daily market newsletter, Get Real, we looked at Trump’s new tariff targets, a 5G network launch, and turnaround hopes.

Cronos Group, one of the more resilient cannabis stocks, hasn’t escaped the gloom in the cannabis sector. It’s down 37.44% year-to-date on the Nasdaq.

Citigroup has upgraded Altria and downgraded Philip Morris. It expects lower cigarette volume declines and has a favorable outlook on traditional tobacco.

Altria (MO) stock has recovered recently and risen by about 8% in a month. However, the stock has underperformed peers and broader markets this year.

Analysts expect Cronos Group to report revenue of $14.62 million Canadian dollars in fiscal Q3 2019. This implies a YoY (year-over-year) rise of 288.74%.

In today’s Get Real, we saw Tesla’s plans for China, AMD’s expectations for 2020, the state of crude oil prices, and more.

Cannabis company Cronos Group has expanded its presence in the US cannabidiol market through a tie-up with tobacco company Altria Group.

AT&T stock is prospering, while Netflix’s problems could be rising. We also have the latest earnings including U.S. Steel and Chevron today.

Cronos Group (CRON) is one of the most popular Canadian cannabis companies that is set to become a leader. The company involves in the production and sale of marijuana and the sub-products obtained from marijuana with facilities located across five continents. Moreover, the company was set up in 2012, with tobacco company Altria Group (MO) […]

When Altria posted its earnings yesterday, things looked positive. However, after news about Juul Labs, MO stock lost momentum and closed 2.6% lower.

Altria (MO) posted better-than-expected third-quarter earnings results today. As expected, lower cigarette shipment volumes remained a drag.

Altria (MO) is scheduled to report its third-quarter earnings results on October 31. Analysts expect its earnings to continue to improve year-over-year.

Bernie Sanders released his plan to legalize marijuana in the US. He pledged to declassify marijuana as a controlled substance in the first 100 days.

Altria stock has recovered sharply in October. There’s positive momentum in the stock before the company’s earnings. The stock has risen 14% in October.

On October 18, Citigroup upgraded Altria stock to “neutral” from “sell.” It expects the negative news surrounding vaping to boost cigarette volumes.

Philip Morris reported mixed third-quarter results before the markets opened. The company posted revenues of $7.64 billion—up 1.8% YoY.

Philip Morris will announce its third-quarter earnings results on October 17. We believe the pressure on the company’s top line could ease a bit.

Since the lower stock price dented investors’ return, Altria has rewarded its shareholders through higher dividends and share repurchases.

Many hedge funds have been reaping the benefits of a rise in Juul’s valuation. However, they didn’t foresee a massive potential vaping-related issue.

Cannabis legalization is heating up. More states are coming forward to legalize marijuana. Cannabis is also gaining global popularity.

In recent years, vaping devices or e-cigarettes have been considered safer than tobacco cigarettes. However, the rise in vaping is now a matter of concern.

Cronos Group (CRON) reported its Q2 results last month. Despite better-than-expected sales, its Q2 losses widened and its stock has fallen 23% since then.

Vaping has become very popular. However, investigations by the FTC and FDA sparked more concerns. Juul’s vaping devices could cause seizures.

Behemoth tobacco companies Philip Morris (PM) and Altria (MO) might be getting back together after separating more than a decade ago.

On August 23, the markets tumbled due to the escalating trade war. The S&P 500 Index lost around 2.6%. Altria stock held out and lost just 0.4%.

Altria (MO) stock has lagged the broader market in 2019. On August 17, the CDC noted that it is investigating lung diseases linked to e-cigarette use.

Altria (MO) stock has dipped roughly 5% so far in 2019, underperforming the broader market. MO stock is trading about 10% above its 52-week low price.

As the broader markets take a hit, dividend-paying consumer stocks seem like a safe bet due to the sector’s defensive nature.

On Thursday, Canopy Growth announced its entry into the US vaporizer market. The company entered into a distribution agreement with Greenlane Holdings.

During its latest earnings call, Aphria (APHA) stated that vapes and concentrates could form a major share of Canada’s recreational market by 2021.

This year, Altria (MO) expects its adjusted EPS to grow 4%–7% year-over-year to $4.15–$4.27. It’s investing in product expansion and loyalty programs.

Altria Group (MO) reported its second-quarter results yesterday. Its stock fell to a low of $47.35 before closing at $48.50.

Today, Altria Group (MO) reported its second-quarter earnings results. In the quarter, the company had adjusted EPS of $1.10.

Altria Group (MO) is set to report its second-quarter earnings before the market opens on July 30. In the quarter, analysts expect the company’s revenue and EPS to rise.

Philip Morris International (PM) reported its second-quarter earnings results on Thursday. The company reported adjusted EPS of $1.46.

On Friday, Goldman Sachs upgraded Altria Group (MO) from a “neutral” to a “buy” while keeping its price target unchanged at $59.

Philip Morris International (PM) was trading at $77.38, which represents a fall of 9.5% since its first-quarter earnings on April 18.

As of June 21, Altria was trading at a forward PE ratio of 11.1x—compared to 12.8x before its first-quarter earnings were announced. Altria posted its first-quarter earnings on April 25.

Scott Gottlieb’s comments might have led to a fall in Altria’s stock price on June 21. At the closing on June 21, the company was trading at $48.00—a fall of 4.5% from the previous day’s closing price.

On June 3, Altria Group (MO) announced that it signed a definitive agreement to acquire 80% of the stake in Burger Söhne Holding.

For 2019, Altria’s management expects the company to post a diluted EPS of $4.15–$4.27, which represents 4%–7% growth from $3.99 in 2018.

As of May 30, Altria Group (MO) was trading at $50.21—a fall of 8.2% since its first-quarter earnings on April 25.

Altria Group (MO) reported its first-quarter earnings on April 25.

On May 28, Altria Group (MO) fell 4.8%, while British American Tobacco (BTI) fell 4.1%.

Today, Philip Morris International (PM) was trading ~0.8% higher at 11:05 AM EST.

For the first quarter of 2019, Altria Group (MO) has posted revenue, net of excise tax, of $4.39 billion against analysts’ estimate of $4.59 billion.

Altria failed to meet analysts’ revenue and EPS expectations for the first quarter.

Despite strong first-quarter results, Philip Morris was trading in the red early on April 18.

Analysts expect Philip Morris International (PM) to post revenue of $6.74 billion in the first quarter.

Despite 10.5% growth in the first quarter, the Consumer Staples Select Sector SPDR ETF (XLP) lagged the benchmark index, which rose 13.1%.

The FDA’s announcement caused Altria’s stock price to fall. On April 3, the stock price fell to a low of $53.43 before closing the day at $53.98.

Sin stocks marked healthy growth in the first quarter. Molson Coors and Brown-Forman stocks rose 6.2% and 10.9%, respectively.

The Consumer Staples Select Sector SPDR ETF (XLP) rose 10.5% in the first quarter of 2019.

For 2019, analysts are expecting Philip Morris International (PM) to post revenue of $30.68 billion, which represents a rise of 3.6% from $29.63 billion in 2018.

Philip Morris International (PM) posted a net revenue excluding excise tax of $29.63 billion in 2018.

On March 8, Altria (MO) announced that it completed its previously announced investment of ~$1.8 billion in Cronos Group.

In an interview with Yahoo Finance, Jeffrey Gundlach described cannabis as a commodity like corn, implying that it has no intellectual property potential.

For 2019, analysts expect Philip Morris International (PM) to report revenue of $30.69 billion, which represents growth of 3.6% from $29.63 billion in 2018.

The strengthening broader equity market and strong fourth-quarter earnings have increased Philip Morris’s (PM) stock price, which has led to an increase in its valuation multiple.

After losing 36.8% of its stock value in 2018, Philip Morris International (PM) began 2019 on a strong note.

According to a Bloomberg report on February 22, JUUL Lab’s management expects its revenues to rise to $3.4 billion in 2019.

In the third quarter of fiscal 2019, Pyxus International (PYX) posted revenue of $524.5 million, a rise of 9.8% year-over-year.

Pyxus International (PYX) posted its fiscal 2019 third-quarter earnings results after the market closed on February 11.

Altria Group (MO) posted its fourth-quarter earnings on January 31. During the quarter, the company’s EPS met analysts’ expectations.

On December 7, Altria Group (MO) announced that it had invested $1.8 billion in Cronos Group (CRON) for a 45% stake in the company, which could increase 10% over the next four years.

On December 20, Altria Group (MO) announced a $12.8 billion investment in JUUL Labs for a 35% stake in the e-cigarette company.

In December, Altria Group (MO) made two big announcements. First, on December 7, Altria announced that it would invest $1.8 billion in Cronos Group (CRON).

In the fourth quarter, Philip Morris International (PM) posted revenue of $7.50 billion, outperforming analysts’ expectation of $7.39 billion.